NasdaqGS - Delayed Quote USD

Bio-Techne Corporation (TECH)

80.91 +1.36 (+1.71%)
At close: May 10 at 4:00 PM EDT
81.17 +0.26 (+0.32%)
After hours: May 10 at 7:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
1,154,281.00
1,136,702.00
1,105,599.00
931,032.00
738,691.00
Cost of Revenue
383,206.00
366,887.00
349,103.00
298,182.00
255,497.00
Gross Profit
771,075.00
769,815.00
756,496.00
632,850.00
483,194.00
Operating Expense
523,633.00
478,817.00
460,668.00
390,160.00
334,347.00
Operating Income
247,442.00
290,998.00
295,828.00
242,690.00
148,847.00
Net Non Operating Interest Income Expense
-13,476.00
-7,805.00
-10,515.00
-13,479.00
-18,592.00
Other Income Expense
-1,622.00
55,466.00
16,073.00
-81,036.00
146,222.00
Pretax Income
232,344.00
338,659.00
301,386.00
148,175.00
276,477.00
Tax Provision
29,343.00
53,217.00
38,287.00
8,590.00
47,181.00
Net Income Common Stockholders
202,959.00
285,193.00
271,930.00
140,324.00
229,072.00
Diluted NI Available to Com Stockholders
202,959.00
285,193.00
271,930.00
140,324.00
229,072.00
Basic EPS
1.28
1.81
1.73
0.91
1.50
Diluted EPS
1.25
1.76
1.66
0.87
1.46
Basic Average Shares
157,617.00
157,179.00
156,874.00
154,986.00
152,804.00
Diluted Average Shares
161,141.75
161,855.00
164,114.00
161,932.00
157,604.00
Total Operating Income as Reported
255,388.00
298,944.00
296,590.00
237,296.00
157,419.00
Total Expenses
906,839.00
845,704.00
809,771.00
688,342.00
589,844.00
Net Income from Continuing & Discontinued Operation
203,001.00
285,263.00
272,051.00
140,410.00
229,296.00
Normalized Income
197,397.03
237,936.98
259,294.72
217,593.71
108,371.43
Interest Income
3,453.00
3,410.00
794.00
473.00
605.00
Interest Expense
16,929.00
11,215.00
11,309.00
13,952.00
19,197.00
Net Interest Income
-13,476.00
-7,805.00
-10,515.00
-13,479.00
-18,592.00
EBIT
249,273.00
349,874.00
312,695.00
162,127.00
295,674.00
EBITDA
359,850.00
457,112.00
413,764.00
249,874.00
378,411.00
Reconciled Cost of Revenue
383,206.00
291,725.00
280,526.00
238,223.00
199,118.00
Reconciled Depreciation
110,577.00
107,238.00
101,069.00
87,747.00
82,737.00
Net Income from Continuing Operation Net Minority Interest
203,001.00
285,263.00
272,051.00
140,410.00
229,296.00
Total Unusual Items Excluding Goodwill
6,414.00
56,140.00
14,612.00
-81,936.00
145,868.00
Total Unusual Items
6,414.00
56,140.00
14,612.00
-81,936.00
145,868.00
Normalized EBITDA
353,436.00
400,972.00
399,152.00
331,810.00
232,543.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
810.03
8,813.98
1,855.72
-4,752.29
24,943.43
6/30/2020 - 2/9/1989

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RVMD Revolution Medicines, Inc.
37.25
-0.53%
 
GMAB Genmab A/S
28.84
+0.10%
 
LEGN Legend Biotech Corporation
43.24
-5.01%
 
UTHR United Therapeutics Corporation
264.27
-0.67%
 
PCVX Vaxcyte, Inc.
65.19
-0.58%
 
INCY Incyte Corporation
53.06
-0.82%
 
ROIV Roivant Sciences Ltd.
11.13
-1.07%
 
BGNE BeiGene, Ltd.
161.13
-4.45%
 
JAZZ Jazz Pharmaceuticals plc
109.63
-3.09%
 
ARGX argenx SE
374.63
-2.07%